AKT1 and neoplasm: Similarly, the phosphorylation of EGFR’s serine 229, by AKT, also promotes the nuclear translocation of EGFR [21], which acts as a co-transcription factor of multiple genes, regulating cell proliferation and tumor angiogenesis, resulting in enhanced drug resistance and poor patient outcomes [22].